Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study
Andreas O Doesch,1 Susanne Mueller,1 Christian Erbel,1 Christian A Gleissner,1 Lutz Frankenstein,1 Stefan Hardt,1 Arjang Ruhparwar,2 Philipp Ehlermann,1 Thomas Dengler,3 Hugo A Katus1 1Department of Cardiology, 2Department of Cardiovascular Surgery, University of Heidelberg, Heidelberg, 3SLK Platte...
Main Authors: | Doesch AO, Mueller S, Erbel C, Gleissner CA, Frankenstein L, Hardt S, Ruhparwar A, Ehlermann P, Dengler T, Katus HA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-11-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/heart-rate-reduction-for-36-months-with-ivabradine-reduces-left-ventri-peer-reviewed-article-DDDT |
Similar Items
-
Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation
by: Doesch AO, et al.
Published: (2013-10-01) -
Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation
by: Gueler I, et al.
Published: (2013-04-01) -
Conversion to generic cyclosporine A in stable chronic patients after heart transplantation
by: Kraeuter M, et al.
Published: (2013-11-01) -
Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen
by: Helmschrott M, et al.
Published: (2014-09-01) -
Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
by: Doesch AO, et al.
Published: (2012-10-01)